Development of a predictive model integrating urogenital pathogens and inflammatory markers for human papillomavirus infection

开发一种整合泌尿生殖系统病原体和炎症标志物的预测模型,用于预测人乳头瘤病毒感染

阅读:1

Abstract

OBJECTIVE: The objective of the present study was to evaluate the relationship between common urogenital pathogens and human papillomavirus (HPV) infection and to assess the impact of coinfections on vaginal microecology. METHODS: This hospital-based cross-sectional study included 330 reproductive-aged women. Multiplex polymerase chain reaction (PCR) was applied to detect Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), Mycoplasma hominis (MH), and Mycoplasma genitalium (MG). HPV DNA genotyping was also performed. Clinical characteristics and laboratory results were evaluated using univariate and multivariate logistic regression analyses to identify independent risk factors for HPV infection. A logistic regression model was constructed, and its predictive performance was evaluated by receiver operating characteristic (ROC) curve and calibration analyses. RESULTS: The overall HPV positivity rate was 46.4%. Univariate analysis revealed associations of HPV infection with CT, NG, UU, UP, MH, elevated leukocyte count, and vaginitis (all P < 0.05). Multivariate analysis revealed that CT infection (aOR=4.115), UU infection (aOR=3.937), elevated leukocyte count (aOR=2.076), and abnormal vaginal discharge (aOR=2.987) were independent predictors for HPV. The prediction model demonstrated good discrimination (AUC≈0.85). In addition, UU, MH, CT, and UP infections were significantly linked to bacterial vaginosis and other vaginal disorders. CONCLUSIONS: CT and UU infections are strongly associated with HPV infection. Elevated leukocyte count and abnormal vaginal discharge serve as inflammatory indicators that increase prediction accuracy. The proposed model, which integrates pathogen detection and host inflammatory status, performs well in identifying women at high risk of HPV, thereby supporting early screening and cervical cancer prevention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。